{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
CARE Ratings Ltd
CARE Ratings: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals
CARE Ratings has experienced a revision in its market assessment following a detailed evaluation of its quality, valuation, financial trends, and technical indicators. Despite positive quarterly financial results, the stock’s recent price movements and long-term growth metrics have influenced a nuanced shift in its overall outlook.
CARE Ratings Technical Momentum Shifts Amid Mixed Market Signals
CARE Ratings has experienced a notable shift in its technical momentum, reflecting a transition from a sideways trend to a mildly bearish stance. This change is underscored by a variety of technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, which collectively paint a nuanced picture of the stock’s near-term trajectory within the capital markets sector.
How has been the historical performance of CARE Ratings?
CARE Ratings has shown consistent growth in net sales and profit, with net sales increasing from 247.63 crore in March 2022 to 402.32 crore in March 2025, and profit after tax rising from 76.83 crore to 140.00 crore during the same period, reflecting strong financial health.
CARE Ratings Technical Momentum Shifts Amid Mixed Market Signals
CARE Ratings has experienced a notable shift in its technical momentum, reflecting a complex interplay of market indicators that suggest a transition from a mildly bullish trend to a sideways movement. This development comes amid mixed signals from key technical indicators such as MACD, RSI, and moving averages, underscoring a nuanced market assessment for the capital markets firm.
CARE Ratings Sees Revision in Market Evaluation Amid Mixed Financial Signals
CARE Ratings has experienced a revision in its market evaluation, reflecting nuanced shifts across key financial and technical parameters. This adjustment comes amid a backdrop of steady operational performance and valuation considerations within the capital markets sector.
Why is CARE Ratings falling/rising?
As of 20-Nov, CARE Ratings Ltd's stock price is at 1,511.00, down 1.23%, underperforming against the Sensex, which has gained 1.37%. Despite strong fundamentals, declining investor participation and recent performance metrics are contributing to the stock's downward trend.
Has CARE Ratings declared dividend?
Yes, CARE Ratings Ltd has declared an 80% dividend, amounting to ₹7 per share, with an ex-date of November 5, 2024. The company has shown positive total returns across various periods, with a total return of 270.99% over the last 5 years.
CARE Ratings Q2 FY26: Strong Revenue Surge Masks Margin Volatility Concerns
CARE Ratings Ltd., India's leading credit rating agency, delivered a robust quarter-on-quarter performance in Q2 FY26, posting consolidated net profit of ₹56.67 crores—a dramatic 119.82% surge from the previous quarter's ₹25.78 crores. The ₹4,829-crore market capitalisation company demonstrated strong revenue momentum with net sales climbing 45.21% sequentially to ₹136.37 crores, marking the highest quarterly revenue in the company's recent history.
How has been the historical performance of CARE Ratings?
CARE Ratings has demonstrated consistent growth in net sales and profits, with net sales increasing from 247.63 crore in March 2022 to 402.32 crore in March 2025, and profit after tax rising from 76.83 crore to 140.00 crore during the same period. The company has maintained a strong financial position, reflected in its growing total assets and operating profit.
Why is CARE Ratings falling/rising?
As of 13-Nov, CARE Ratings Ltd's stock price is rising to Rs 1,605.20, reflecting a 5.56% increase. The stock has shown strong performance with a year-to-date return of 18.44%, supported by positive financial indicators and growing investor confidence.
CARE Ratings Soars 7.72%, Hits Intraday High of Rs 1643.15
CARE Ratings has seen a notable rise today, recovering from a previous decline and outperforming its sector. The stock remains above several key moving averages, indicating a mixed short-term outlook. Over the past year, it has significantly outperformed the Sensex, showcasing resilience in the capital markets sector.
How has been the historical performance of CARE Ratings?
CARE Ratings has shown consistent growth in net sales and profit, with net sales increasing from 247.63 crore in March 2022 to 402.32 crore in March 2025, and profit after tax rising from 76.83 crore to 140.00 crore in the same period, reflecting a strong financial position and enhanced shareholder value.
Why is CARE Ratings falling/rising?
As of 12-Nov, CARE Ratings Ltd's stock price is at 1,519.20, down 4.87% after three consecutive days of decline. Despite recent underperformance, the company has shown strong financial growth over the past eight quarters and has outperformed the Sensex year-to-date.
Why is CARE Ratings falling/rising?
As of 07-Nov, CARE Ratings Ltd is currently priced at 1,621.00, reflecting a 1.12% increase. The stock has shown strong performance, outperforming its sector and delivering significant year-to-date returns, despite a decline in delivery volume indicating potential concerns about investor participation.
Is CARE Ratings technically bullish or bearish?
As of October 6, 2025, the trend is mildly bullish due to daily moving averages, but caution is advised due to mixed signals from the weekly MACD and KST, with the monthly RSI remaining bearish.
CARE Ratings Shows Mixed Technical Trends Amid Strong Long-Term Performance
CARE Ratings, a small-cap player in the capital markets sector, has shown strong performance over the past year with a return of 33.71%, significantly outperforming the Sensex. Despite recent price fluctuations, its long-term returns over three and five years remain robust, highlighting its market resilience.
Is CARE Ratings technically bullish or bearish?
As of 29 September 2025, the trend is mildly bullish due to daily moving averages, but caution is advised as weekly indicators show mild bearishness, creating mixed signals overall.
CARE Ratings Experiences Mixed Technical Trends Amid Strong Long-Term Performance
CARE Ratings, a small-cap firm in the capital markets sector, has recently revised its evaluation amid changing market conditions. The stock has shown strong long-term performance, with notable returns year-to-date and over the past year, significantly outperforming the Sensex and demonstrating resilience in the market.
Is CARE Ratings technically bullish or bearish?
As of September 26, 2025, CARE Ratings exhibits a neutral technical stance with mixed signals, as weekly indicators are mostly bearish while monthly indicators show some bullishness, indicating a lack of clear direction.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
